Hospital Acquired Infection Treatment Market Size and Forecasts (2020 – 2030)

Hospital Acquired Infection Treatment Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs, and Others), Infection Type (Urinary Tract Infections, Ventilator-Associated Pneumonia, Surgical Site Infections, Bloodstream Infections, and Other Hospital Infections), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPRE00029976 Category: Tags: , ,

$3,633$6,433

Description

The global hospital-acquired infection treatment market is expected to reach US$ 19.978 billion in 2030 from US$ 15.099 billion in 2022. The market is estimated to grow with a CAGR of 3.6% from 2022 to 2030.
The key factors driving the market’s growth include the high prevalence of hospital-acquired infections (HAI) and the growing focus on patient safety and quality care. However, the threat of antimicrobial resistance hinders market growth.
Market Drivers of the Hospital-Acquired Infection Treatment Market
Central line-associated bloodstream infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia are a few examples of healthcare-associated infections (HAIs). These infections can also arise at surgical sites. According to the Centers for Disease Control and Prevention (CDC) report “2020 National and State Healthcare-Associated Infections Progress Report” published in 2021, cases of central line-associated bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, and ventilator-associated events increased by 24%, 35%, and 15%, respectively, in the US between 2019 and 2020.
Furthermore, According to the January 2022 report from the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the fifth most common type of healthcare-associated infection. UTIs account for more than 9.5% of acute care hospital conditions. Catheter-associated urinary Tract Infection (CAUTI) is caused by urinary catheters used to drain urine from the bladder. CAUTI is one of the most frequent infections among hospitalized UTI patients. According to the Centers for Disease Control and Prevention (CDC), nearly 75% of infections are related to a urinary catheter. During hospital stays, 15% to 25% of hospitalized patients must use urinary catheters. Prolonged urinary catheter use is the most major risk factor for getting CAUTI. CAUTI complications entail patient suffering, prolonged hospital stays, increased treatment costs, and even death.
Opportunities in the Hospital-Acquired Infection Treatment Market
The continuous development of novel antimicrobial agents, including antibiotics, antifungals, and antivirals, presents opportunities for combating HAIs, addressing emerging resistance patterns, and expanding the armamentarium of treatment options. Additionally, collaborative initiatives among healthcare institutions, pharmaceutical companies, and research organizations present opportunities for discovering novel therapeutic targets, discovering antibiotics, and developing next-generation infection treatment strategies.
Hospital Acquired Infection Treatment Market: Segmental Overview
The hospital acquired infection treatment market, by drug class, is segmented into antibacterial, antiviral, antifungal, and others. The antibacterial drugs segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The hospital acquired infection treatment market, by infection type, is segmented into urinary tract infections, ventilator-associated pneumonia, surgical site infections, bloodstream infections, and other hospital infections. The urinary tract infections segment held the largest market share in 2022. However, the ventilator-associated pneumonia segment is anticipated to register the highest CAGR from 2022 to 2030.
The hospital acquired infection treatment market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, e-commerce, and others. In 2022, the hospital pharmacies segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022–2030.
Hospital Acquired Infection Treatment Market: Geographical Overview
Asia Pacific is estimated to register the highest CAGR from 2022 to 2030. Countries in the Asia Pacific, such as India and China, hold significant potential for the hospital-acquired infection treatment market growth. Developing countries in the region with improving healthcare infrastructure, increasing healthcare expenditure, and a rising focus on adopting advanced medical technologies offer opportunities for market expansion.
In 2022, North America held the largest share of the global hospital-acquired infection treatment market. The US has a high prevalence of HAI, which propels the hospital-acquired infection treatment market growth. As per the CDC, on any given day, about 1 in 31 hospital patients has at least one HAI. Similarly, according to the Office of Disease Prevention and Health Promotion, HAIs and other infections can lead to sepsis, and it causes 1.7 million illness cases and 270,000 deaths per year in the US. Thus, the high prevalence of HAI among people in the US fuels the hospital-acquired infection treatment market growth.
Furthermore, according to the US Centers for Medicare & Medicaid Services, national healthcare expenditures in the US will increase by 2.7 percent in 2021, reaching US$ 4.3 trillion or US$ 12,914 per person. Also, health spending accounted for 18.3 percent of the nation’s Gross Domestic Product. Furthermore, according to the US Department of Health & Human Services, National health spending is expected to grow at a 5.4% annual rate from 2019 to 2028, and it is expected to reach US$ 6.2 trillion by 2028. The rising health expenditure is estimated to increase various funding sources in the research related to the development of HAI drugs, fueling the demand for hospital-acquired infection treatment.

A few of the major primary and secondary sources referred to while preparing the report on the hospital-acquired infection treatment market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

In progress

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Autonomous Mobile Robots Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. North America Autonomous Mobile Robots Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Proliferation of E-Commerce Industry
5.1.2 Growing Demand for Automated Systems
5.2 Market Restraints
5.2.1 High Cost of Autonomous Mobile Robots
5.3 Market Opportunities
5.3.1 Introduction of Advanced and Smart AMR
5.4 Future Trends
5.4.1 Industry-Specific Applications
5.5 Impact Analysis of Drivers and Restraints
6. Autonomous Mobile Robots Market – North America Market Analysis
6.1 North America Autonomous Mobile Robots Market Overview
6.2 North America Autonomous Mobile Robots Market Forecast and Analysis
7. North America Autonomous Mobile Robots Market Analysis – by Component
7.1 Overview
7.2 Autonomous Mobile Robots Market Breakdown, By Component, 2022 and 2030
7.3 Hardware
7.3.1 Overview
7.3.2 Hardware Autonomous Mobile Robots Market Forecast and Analysis
7.4 Software & Services
7.4.1 Overview
7.4.2 Software & Services Autonomous Mobile Robots Market Forecast and Analysis
8. North America Autonomous Mobile Robots Market Analysis – By Type
8.1 Overview
8.2 Autonomous Mobile Robots Market Breakdown, by Type, 2022 and 2030
8.3 Picking Robots
8.3.1 Overview
8.3.2 Picking Robots Autonomous Mobile Robots Market Revenue and Forecast to 2030 (US$ Million)
8.4 Self-Driving Forklifts
8.4.1 Overview
8.4.2 Self-Driving Forklifts Market Revenue and Forecast to 2030 (US$ Million)
8.5 Autonomous Inventory Robots
8.5.1 Overview
8.5.2 Autonomous Inventory Robots Market Revenue and Forecast to 2030 (US$ Million)
9. North America Autonomous Mobile Robots Market Analysis– End Use
9.1 Overview
9.2 Autonomous Mobile Robots Market Breakdown, by End Use, 2022 and 2030
9.3 Manufacturing
9.3.1 Overview
9.3.2 Manufacturing Autonomous Mobile Robots Market Forecast and Analysis
9.3.3 Automotive
9.3.3.1 Overview
9.3.3.2 Autonomous Mobile Robots Market, by Automotive – Forecast and Analysis
9.3.4 Aerospace
9.3.4.1 Overview
9.3.4.2 Autonomous Mobile Robots Market, by Aerospace – Forecast and Analysis
9.3.5 Electronics
9.3.5.1 Overview
9.3.5.2 Autonomous Mobile Robots Market, by Electronics – Forecast and Analysis
9.3.6 Chemicals
9.3.6.1 Overview
9.3.6.2 Autonomous Mobile Robots Market, by Chemicals – Forecast and Analysis
9.3.7 Others
9.3.7.1 Overview
9.3.7.2 Autonomous Mobile Robots Market, by Others – Forecast and Analysis
9.4 Distribution and Warehousing
9.4.1 Overview
9.4.2 Distribution and Warehousing Autonomous Mobile Robots Market Forecast and Analysis
10. Autonomous Mobile Robots Market – Country Analysis
10.1 North America: Autonomous Mobile Robots Market
10.1.1 North America: Autonomous Mobile Robots Market, by Key Country
10.1.1.1 US: Autonomous Mobile Robots Market – Revenue, and Forecast to 2030 (US$ Million)
10.1.1.1.1 US: Autonomous Mobile Robots Market, by Component
10.1.1.1.2 US: Autonomous Mobile Robots Market, by Type
10.1.1.1.3 US: Autonomous Mobile Robots Market, by End Use
10.1.1.1.3.1 US: Autonomous Mobile Robots Market, by Manufacturing
10.1.1.2 Canada: Autonomous Mobile Robots Market – Revenue, and Forecast to 2030 (US$ Million)
10.1.1.2.1 Canada: Autonomous Mobile Robots Market, by Component
10.1.1.2.2 Canada: Autonomous Mobile Robots Market, by Type
10.1.1.2.3 Canada: Autonomous Mobile Robots Market, by End Use
10.1.1.2.3.1 Canada: Autonomous Mobile Robots Market, by Manufacturing
10.1.1.3 Mexico: Autonomous Mobile Robots Market – Revenue, and Forecast to 2030 (US$ Million)
10.1.1.3.1 Mexico: Autonomous Mobile Robots Market, by Component
10.1.1.3.2 Mexico: Autonomous Mobile Robots Market, by Type
10.1.1.3.3 Mexico: Autonomous Mobile Robots Market, by End Use
10.1.1.3.3.1 Mexico: Autonomous Mobile Robots Market, by Manufacturing
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Product Development
11.4 Mergers & Acquisitions
12. Company Profiles
12.1 OMRON Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Milvus Robotics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Geekplus Technology Co Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ABB Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Clearpath Robotics Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Locus Robotics Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boston Dynamics Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Teradyne Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kivnon Logistica SLU
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About
13.2 Word Index

In progress
In progress

The List of Companies – Hospital Acquired Infection Treatment Market
– Merck & Co Inc
– Pfizer Inc
– AbbVie Inc
– Paratek Pharmaceuticals Inc
– Eugia US LLC
– Abbott Laboratories
– Cumberland Pharmaceuticals Inc
– Innoviva Specialty Therapeutics Inc
– Cipla Ltd
– Eli Lilly and Company

Reviews

There are no reviews yet.

Be the first to review “Hospital Acquired Infection Treatment Market Size and Forecasts (2020 – 2030)”